JoVE Logo

Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Results
  • Discussion
  • Disclosures
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

Perineural invasion (PNI) is a common feature of head and neck squamous cell carcinoma (HNSCC), conferring lower survival rates. Its mechanisms are poorly understood. Utilizing neurites generated from murine dorsal root ganglia confined to a semisolid matrix, the pathways involved in the PNI of HNSCC cell lines can be investigated.

Abstract

Perineural invasion (PNI) is found in approximately 40% of head and neck squamous cell carcinomas (HNSCC). Despite multimodal treatment with surgery, radiation, and chemotherapy, locoregional recurrences and distant metastases occur at higher rates, and overall survival is decreased by 40% compared to HNSCC without PNI. In vitro studies of the pathways involved in HNSCC PNI have historically been challenging given the lack of a consistent, reproducible assay. Described here is the adaptation of the dorsal root ganglion (DRG) assay for the examination of PNI in HNSCC. In this model, DRG are harvested from the spinal column of a sacrificed nude mouse and placed within a semisolid matrix. Over the subsequent days, neurites are generated and grow in a radial pattern from the cell bodies of the DRG. HNSCC cell lines are then placed peripherally around the matrix and invade preferentially along the neurites toward the DRG. This method allows for rapid evaluation of multiple treatment conditions, with very high assay success rates and reproducibility.

Introduction

Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer in the US, with 10,000 deaths per year nationally and 300,000 deaths per year worldwide1. The overall prognosis for HNSCC has remained unchanged at 50% for the past several decades. Perineural invasion (PNI) is one of the most prominent pathological features that portend a poor prognosis in patients with HNSCC. Unfortunately, PNI is a frequent occurrence in HNSCC and can be found in up to 40% of HNSCC patients2,3.

PNI is the process by which malignant cells track along nerves to adjacent tissues, allowing for higher rates of local and distant spread. Accordingly, PNI-positive HNSCC tumors have higher rates of locoregional recurrences and distant metastases, resulting in lower overall survival compared to HNSCC patients without PNI4-8.

Although the treatment of patients with PNI is typically maximized by employing surgery, radiation, and chemotherapy, the overall survival rates of these patients are still decreased by up to 40% compared to patients without PNI9-11. Thus, it is clear that the current treatment modalities for HNSCC are ineffective in improving the adverse prognosis associated with PNI. The approach of developing targeted therapy against PNI in HNSCC has been hindered by the poor understanding of the factors that regulate this process. This is, in part, a consequence of the lack of a consistent in vitro model for the study of PNI in HNSCC.

In recent years, several groups have been utilizing an in vitro model for studying PNI in predominantly pancreatic and prostate cancers12-19. This model uses the neurites generated from dorsal root ganglia isolated from mice or rats as a surrogate for large-nerve invasion. The dorsal root ganglia are fixed in a factor-depleted semisolid matrix, which is a solubilized basement membrane protein mixture secreted by Engelbreth-Holm-Swarm mouse sarcoma cells. This matrix allows for the outgrowth of the neurites and the tracking of single cancer cells along these neurites. Described here is the adaption of this model for the examination of PNI in HNSCC.

Protocol

1. Preparation of Culture Medium and Dishes (10 min)

  1. Add 100 µL of Dulbecco's Modified Eagle Medium (DMEM) with 10% fetal bovine serum (FBS) to the wells of a 96-well V-bottom plate.
  2. Remove a pre-aliquoted-vial of approximately 100 µL of semisolid matrix from the 20 °C freezer and place it directly on ice.
    NOTE: Do this prior to the dorsal root ganglion (DRG) harvest because the semisolid matrix takes approximately 30 min to reach liquid state on ice, which is necessary for the subsequent steps. Failure to keep the semisolid matrix on ice at all times will result a poor-quality matrix droplet.
  3. Label glass-bottom cultures plates with permanent ink, creating unique identifiers in each of the four corners on the undersurface of the plate. Place the plates right-side up on ice to cool the plate surface.
    NOTE: Each mouse yields 32 - 40 DRG, so label them from 1 to 40. It is not necessary to pre-chill pipet tips, as chilled tips will warm over the course of placing the matrix droplets, potentially introducing differences in matrix consistency.

2. Dissection of Murine DRG (45 min)

  1. Euthanize an athymic nude mouse as per specific laboratory protocols, such as through the use of a CO2 chamber and a thoracotomy.
  2. Set up the dissection area and microscope. Use the clean, sterilized, and flat underside of polystyrene containers for 15- or 50-mL conical tubes.
    NOTE: Additionally, they are suitable for use as the dissecting surface, as they are inexpensive, disposable, and allow for fixation of the spine using pins or needles. Only use sterilized instruments and needles.
  3. Under natural vision, make a longitudinal incision along the spinal column from the root of the tail to the head of the mouse with a pair of straight or curved fine scissors.
  4. Use the same scissors to transversely divide below the sacral spine. Dissect both sides of the spine all the way up to the skull base using the scissors. At this point, ensure that the cervical spine is transected cranially as far as possible with scissors.
  5. Observe the cervical end of the spinal column under the operating microscope at low power. The white spinal cord is apparent in the middle of a bony ring, which is surrounded by variable amounts of paraspinal muscles and soft tissue.
  6. Split the dorsal or superior aspect of the first 2 - 3 vertebral bodies with microscopic spring scissors. Using the spring action of the scissors, open this initial bony cut to ensure that the vertebral body dissection occurred at the midline. Continue in small increments towards the sacral spine, and then bisect the spine by completing the identical cuts on the ventral or inferior aspect of the vertebral bodies.
    NOTE: Failure to ensure the midline dissection of the bony spinal column will result in a lower DRG yield.
  7. At this point, the spinal column is divided into two halves. Place one hemi-spine aside, with the spinal cord in place and facing down on a sterile plate.
    NOTE: Leaving the spinal cord in place will prevent the DRGs from drying out, as the DRGs are deep to the spinal cord.
  8. Secure either end of the other hemi-spine with two 18-gauge needles on the polystyrene dissecting platform. Starting at the cervical end (which is apparent because the spine is narrower, the DRG are closer to one another, and there are rib insertions), gently peel back the spinal cord from about 4 vertebral levels.
  9. Observe the sensory nerves (usually two) connecting the DRG. In the area where the nerves insert to the DRG, gently grasp the surrounding fascia with microscopic forceps. Dissect and trim this fascia and other nerve tissue with the microscopic spring scissors to free up the DRG. Gentle retraction will bring the DRG out of its position within the bony spine.
    NOTE: Increasing the microscope power at this step is beneficial. Crush injury to the DRG will significantly limit the growth of neurites. This is avoided by never grasping the DRG directly, but rather by grasping the surrounding fascia.
  10. Cut the peripheral nerve (the DRG generally has one peripheral nerve, which is deep relative to the dissecting view) with the microscopic spring scissors to release the DRG.
    NOTE: It is easiest to ascertain where the nerve ends and the DRG begins while on tension, so making this cut as close as possible to the DRG at this point is ideal. Once this distal branch is cut, the proximal branches are trimmed as well.
  11. Trim the DRG of any stray nerve fibers or fascial attachments with the microscopic spring scissors. After adequate isolation, place the DRG into the room-temperature medium within the 96-well V-bottom plate.
    NOTE: Placing a dark background underneath the plate makes visualizing the sub-mm white DRGs easier. Only place one DRG in each well; this way, they can be accounted for more easily in the subsequent steps.
  12. Repeat this process all the way down one hemi-spine and then the other. Each side yields 16 - 20 DRGs, totaling 32 - 40.
    NOTE: If there are fewer DRGs than this, the dissection of the spine needs to be carried out further cephalad and/or caudally. The DRGs become increasingly less well defined as one proceeds caudally.

3. Preparation of Semisolid Matrix Droplets (< 1 min per plate)

  1. Remove one glass well-bottom plate from ice and place it on an ice block underneath the operating microscope. Make sure the aliquot of matrix remains on ice at all times.
  2. Place a 1.5-µL droplet of matrix in each of the four corners of the glass-bottom plate with a 2-µL or 10-µL micropipetter, leaving a distance at least as great as the droplet itself from the edge of the glass well.
    1. Place the tip of the pipette directly onto the glass at a 45-degree angle. Slowly pipet the matrix. Slowly move away from the glass bottom after the matrix is engaged on the plate.
      NOTE: The surface tension between the matrix and glass should create a perfect hemisphere each time.
    2. Stop pipetting just before the tip is empty, because inadvertent injection of air into the matrix droplet makes the diameter of the matrix droplet far greater and is difficult to remove.
      NOTE: Using a second hand to stabilize the pipetting hand facilitates more accurate placement.

4. Insertion of DRG into Semisolid Matrix Droplets (< 2 min per plate)

  1. Leave the plate with the matrix droplets briefly at room temperature (~ 1 min). This slightly stiffens the matrix, making it easier for the precise placement of the DRG.
  2. Scoop (do not grasp) the DRG gently with closed microscopic forceps in the left hand. Again, a dark background against the small, white DRG facilitates visualization. Transfer the DRG to the tip of a 21-gauge needle in the right hand. This transfer will leave residual media on the forceps.
  3. Gently insert the DRG into the middle of the matrix droplet using the 21-gauge needle (Figure 1). Most of the time, the DRG will easily release into the matrix and then can be positioned centrally with the needle.
    1. If the DRG sticks to the needle, use the microscopic forceps to push the DRG off of the needle and into the matrix droplet. Wick away excess media from the microscopic forceps with a lab wipe.
      NOTE: Introducing media to the matrix will alter the diameter, volume, and consistency of the assay. An ice block with color or colored writing provides background contrast, which eases visualization of this delicate process.
  4. After the plate has all four DRGs, perform a final inspection to ensure that the DRG is in the center of the matrix droplet. Make adjustments as needed with the 21-guage needle.
  5. Transfer the completed plate to a 37 °C incubator. This will solidify the semisolid matrix and fix the DRG in position.
  6. Repeat this process for all of the DRGs. Place blank matrix droplets without a DRG as the negative control.
  7. Add 4 mL of DMEM with 10% FBS media to each glass-bottom plate after completing all plates and exposing them to the 37 °C incubator for at least 3 min. Place the plate at a slight angle and slowly add the medium, such that it gradually comes into contact with the matrix-DRG units.
    NOTE: If the medium is added too quickly or vigorously, the matrix and/or DRG can become dislodged.
  8. Store the assays in the 37 °C incubator for the next 48 - 72 h.
    NOTE: Periodic examination of the assays will show circumferential outgrowth of neurites towards the matrix edge (Figure 2). When the neurites are greater than three-fourths of the way to the matrix, it is appropriate to plate the cells.

5. Preparation of the Head and Neck Cancer Cells

NOTE: Cell lines other than head and neck squamous cell carcinoma cells can be used in this experimental design.

  1. Maintain squamous cell carcinoma cell lines in DMEM with 10% FBS in preferred flasks or culture dishes in a 37 °C incubator. To prepare cells for experimentation, suction all the medium from the culture flask or dish and wash it twice with PBS. Suspend the cells by adding an appropriate amount of 0.025% trypsin for 5 min, followed by DMEM with 10% FBS. Pipette 4 mL of the cell and media mixture into 6-mL culture dishes.
    NOTE: A 6-mL culture plate provides more than enough cells, even when less than 50% confluent.
  2. Expose the HNSCC cell lines to different conditions 24 h prior to staining and plating on the DRG assay. Re-dose the condition once the cells are plated to maintain a consistent environment.
    NOTE: Add antibodies, growth factors, cytokines, or other molecules to the cell culture dishes 1 - 2 days following mouse dissection and implantation of the DRG into the matrix.
  3. Add fluorescent cell stains 1 h before plating the cells (2 - 3 days after the DRG harvest and implantation into the matrix).
    NOTE: The particular stains used here pass freely through the cell membrane; however, after reacting with intracellular thiol groups, the stain remains within the cell and is passed on to daughter cells. The staining greatly facilitates visualization within the assays. These temporary stains are ideal for these assays because the fluorescence is present for 2 - 3 days, which is the timeframe of these experiments. It also allows for the use of many different colors and obviates the need for creating fluorescent protein-transfected cell lines.
    1. Prepare 10 µM of dye solution by mixing 2 µL of 10 mM stock cell stains in 2 mL of serum-free DMEM for every cell condition. Warm this to 37 °C before adding it to cells.
    2. Remove the culture medium within the 6-mL plate, leaving the adherent HNSCC cells on the plate. Add 2 mL of phosphate-buffered saline (PBS) and remove 2 mL of the 10 µM cell stain/serum-free DMEM added to each plate
    3. Return the 6-mL culture plate with the cell stain to the 37 °C incubator for 40 min.
    4. After 40 min, aspirate the medium. Add 2 mL of PBS and then aspirate it. Add 1 mL of 0.025% trypsin to each plate and replace them in the 37 °C incubator.
    5. Add 2 mL of DMEM with 10% FBS after 3 - 5 min and transfer the suspended cells to a 15-mL conical tube. Spin the cells and re-suspended them in 1 mL of DMEM with 10% FBS.
    6. Count the cells with a hemocytometer or automated cell counter, and then add DMEM with 10% FBS to create a final cell concentration of 300,000 cells per mL.

6. Plating Head and Neck Cancer Cells

  1. Remove the glass-bottom plates with the matrix-DRG assays from the incubator.
    NOTE: Again, they are appropriate when neurites are at least 75% of the way to the edge of the matrix, which generally occurs after 2 - 3 days. This is best seen using at least a 10X objective.
  2. Aspirate the medium within the glass-bottom plate. Completely aspirate the medium within the glass well without removing the matrix-DRG units.
  3. Draw up 200 µL of the 300,000 cells/mL medium using a 200-µL pipet. Place two drops of the cells over each matrix-DRG assay. Perform this step for each matrix droplet, creating four repeats of each cell condition on one plate.
    NOTE: The hemispherical shape of the matrix allows the cells to settle in a ring along the periphery of the assay (Figure 3a, Figure 3b). Finding a pipet with a smooth trigger makes placement of uniform drops far easier.
  4. Confirm similar cell numbers and distribution of the various cell conditions under 4X microscopy.
  5. Place the glass-bottom plates into the 37 °C incubator for approximately 60 min. NOTE: Although there is only a small volume of cells and media (~ 150 µL), the assays do not dry out until several hours of incubator time have elapsed.
  6. After 60 min, gently add 4 mL of DMEM with 10% FBS along the sidewall of the glass-bottom plate.
    NOTE: Over a period of time, the cells partially adhere to the plate bottom, and the method of adding the medium does not disturb the cells. Different cell types make take more or less time to begin to adhere to the glass-bottom plate.
  7. Replace any exogenous drugs or growth factors at this time to maintain the previous concentration levels.
  8. Return the assays to the 37 °C incubator, except when they are examined microscopically. Quantify the results of this assay by microscopic imaging. Briefly, count the strands of perineural invasion within four quadrants using a 4X microscopic image.
    NOTE: A microscope with a 4X objective and fluorescence capabilities is adequate for photo-documenting the assays. The size of the assays fits nicely within the field of a 4X objective, which is detailed enough to capture the individual areas of perineural invasion. Perineural invasion becomes apparent within 24 h, but beyond 48 h, the integrity of the assays begins to weaken, as the tumor cells divide along the periphery of the matrix and invade. Beyond 48 h, there is also substantial efflux of fibroblasts from the DRG, which obscures visualization using brightfield microscopy. Therefore, it is advisable to photo-document the results with 4X microscopy at least twice during this window (e.g., at 24 and 48 h after plating the tumor cells). Be mindful that these are 3-dimensional assays, and it is difficult to completely image the entire assay. Most perineural invasion occurs in a plane from the bottom of the plate, where the cells are embedded in the matrix slightly above the bottom of the plate. Because this plane is close to horizontal, the vast majority of neurites with tumor cells are captured in a single-level image at 4X.

Results

After the dissection of the DRG and the placement within the matrix droplet, the appearance of the assay should resemble Figure 1. Note that the DRG is not perfectly round, but it is centered within the matrix droplet. This allows for the outgrowth of neurites in 360 degrees, shown partially in Figure 2. Be aware that certain parts of the DRG send out neurites faster and in greater numbers than others, typically corresponding to where the efferent and aff...

Discussion

Critical Steps within the Protocol

The most important steps within this protocol are the precise dissection and extraction of the dorsal root ganglia. Proper transection of the spinal column and a midline-longitudinal division into two hemi-spines are critical to obtaining large numbers of DRG. During the dissection of individual DRGs, the ganglion should never be handled directly, but rather the surrounding fascia should be grasped with the microscopic forceps. Failure to do ...

Disclosures

The authors have no competing financial interests.

Acknowledgements

This work was supported in whole by funding from the NIH through the R21 grant, "Mechanisms of Perineural Invasion in Head and Neck Cancer" and the NCI T32 training grant, "Post-Doctoral Research Training in Head and Neck Oncology (2T32CA060397-21)." Thank you to Richard Steiman, MD, PhD and lab staff.

Materials

NameCompanyCatalog NumberComments
DMEM/F-12 50/50 Mix with L-glutamine & 15 mM HEPESCorning Cellgro10-090-CVManassas, VA
Fetal bovine serumAtlanta biologicalsS11150Flowery Branch, GA
0.25% Trypsin-EDTA (1x)Life Technologies Corporation25200056Grand Island, NY
Phosphate buffered Saline 1xCorning21-040-CMManassas, VA
Matrigel hESC-Qualif MouseCorning Incorporated354277Bedford, MA
Gamma Irradiated 35 mm glass bottom culture dishesMatTek CorporationP35G-1.5-14-CAshland, MA
SteREO Discovery.V8 Operating MicroscopeCarl Zeiss Microimaging495015-0021-000 Thornwood, NY
Schott ACE I light sourceSchottA20500Germany
CellTracker Life Technologies CorporationC2925Carlsbad, CA
BD PrecisionGlide Needle 18 G and 21 GBD305195Franklin Lakes, NJ
Premium Microdissecting TweezerHarvard Apparatus60-3851Holliston, MA
Premium Fine Operating Standard ScissorsHarvard Apparatus52-2789Holliston, MA
Premium Spring ScissorsHarvard Apparatus60-3923Holliston, MA
Dressing ForcepsHarvard Apparatus72-8949Holliston, MA
Athymic nude mice (002019)Jackson Laboratory002019Bar Harbor, ME

References

  1. Jemal, A., et al. Cancer statistics, 2006. CA Cancer J Clin. 56 (2), 106-130 (2006).
  2. Hinerman, R. W., et al. Postoperative irradiation for squamous cell carcinoma of the oral cavity: 35-year experience. Head Neck. 26 (11), 984-994 (2004).
  3. Rahima, B., Shingaki, S., Nagata, M., Saito, C. Prognostic significance of perineural invasion in oral and oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 97 (4), 423-431 (2004).
  4. Woolgar, J. A., Scott, J. Prediction of cervical lymph node metastasis in squamous cell carcinoma of the tongue/floor of mouth. Head Neck. 17 (6), 463-472 (1995).
  5. Tai, S. K., et al. Treatment for T1-2 oral squamous cell carcinoma with or without perineural invasion: neck dissection and postoperative adjuvant therapy. Ann Surg Oncol. 19 (6), 1995-2002 (2012).
  6. George, D. L., et al. Nosocomial sinusitis in patients in the medical intensive care unit: a prospective epidemiological study. Clin Infect Dis. 27 (3), 463-470 (1998).
  7. Fagan, J. J., et al. Perineural invasion in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 124 (6), 637-640 (1998).
  8. Soo, K. C., et al. Prognostic implications of perineural spread in squamous carcinomas of the head and neck. Laryngoscope. 96 (10), 1145-1148 (1986).
  9. Parsons, J. T., Mendenhall, W. M., Stringer, S. P., Cassisi, N. J., Million, R. R. An analysis of factors influencing the outcome of postoperative irradiation for squamous cell carcinoma of the oral cavity. Int J Radiat Oncol Biol Phys. 39 (1), 137-148 (1997).
  10. Liao, C. T., et al. Does adjuvant radiation therapy improve outcomes in pT1-3N0 oral cavity cancer with tumor-free margins and perineural invasion. Int J Radiat Oncol Biol Phys. 71 (2), 371-376 (2008).
  11. Fan, K. H., et al. Treatment results of postoperative radiotherapy on squamous cell carcinoma of the oral cavity: coexistence of multiple minor risk factors results in higher recurrence rates. Int J Radiat Oncol Biol Phys. 77 (4), 1024-1029 (2010).
  12. Dai, H., et al. Enhanced survival in perineural invasion of pancreatic cancer: an in vitro approach. Hum Pathol. 38 (2), 299-307 (2007).
  13. Ceyhan, G. O., et al. Neural invasion in pancreatic cancer: a mutual tropism between neurons and cancer cells. Biochem Biophys Res Commun. 374 (3), 442-447 (2008).
  14. Gil, Z., et al. Paracrine regulation of pancreatic cancer cell invasion by peripheral nerves. J Natl Cancer Inst. 102 (2), 107-118 (2010).
  15. He, S., et al. GFRalpha1 released by nerves enhances cancer cell perineural invasion through GDNF-RET signaling. Proc Natl Acad Sci U S A. 111 (19), 2008-2017 (2014).
  16. He, S., et al. The chemokine (CCL2-CCR2) signaling axis mediates perineural invasion. Mol Cancer Res. 13 (2), 380-390 (2015).
  17. Bakst, R. L., et al. Radiation impairs perineural invasion by modulating the nerve microenvironment. PLoS One. 7 (6), 39925 (2012).
  18. Ayala, G. E., et al. In vitro dorsal root ganglia and human prostate cell line interaction: redefining perineural invasion in prostate cancer. Prostate. 49 (3), 213-223 (2001).
  19. Na'ara, S., Gil, Z., Amit, M. In Vitro Modeling of Cancerous Neural Invasion: The Dorsal Root Ganglion. J Vis Exp. (110), (2016).

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Explore More Articles

Perineural InvasionHead And Neck Squamous Cell CarcinomaDorsal Root GanglionDRG DissectionMouse ModelSpinal CordPeripheral NerveTissue DissectionMicroscopic Procedures

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved